THAR vs UNH

Score Change Explanation: The previous analysis and score (2.2/10 or 22/100) were for Tharimmune Inc., a micro-cap biotech company focused on clinical trials. The current analysis, based on the real-time market intelligence, is for Tharisa plc, an entirely different entity: a platinum group metals (PGM) and chrome producer. Due to this fundamental change in the company under review, the previous s...

UnitedHealth Group (UNH) remains a healthcare titan, but its sheer scale and the highly regulated nature of its operations fundamentally limit its 10x growth potential within 3-5 years. The recent Optum Health operating loss of $278M in 2025 (compared to $7.77B income in 2024) is a significant concern, eroding the growth narrative that Optum once provided. Furthermore, the proposed 0.09% Medicare ...